GB1589585A - 12a-halocorticoids - Google Patents

12a-halocorticoids Download PDF

Info

Publication number
GB1589585A
GB1589585A GB28994/77A GB2899477A GB1589585A GB 1589585 A GB1589585 A GB 1589585A GB 28994/77 A GB28994/77 A GB 28994/77A GB 2899477 A GB2899477 A GB 2899477A GB 1589585 A GB1589585 A GB 1589585A
Authority
GB
United Kingdom
Prior art keywords
compound
methyl
dione
general formula
pregnadiene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB28994/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of GB1589585A publication Critical patent/GB1589585A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0023—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
    • C07J5/003—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
    • C07J5/0038—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes by an alkyl group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GB28994/77A 1976-07-16 1977-07-11 12a-halocorticoids Expired GB1589585A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2632678A DE2632678C2 (de) 1976-07-16 1976-07-16 6α-Fluor-12α-Halogen-Kortikoide und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
GB1589585A true GB1589585A (en) 1981-05-13

Family

ID=5983515

Family Applications (1)

Application Number Title Priority Date Filing Date
GB28994/77A Expired GB1589585A (en) 1976-07-16 1977-07-11 12a-halocorticoids

Country Status (11)

Country Link
JP (1) JPS5315361A (US06650917-20031118-M00005.png)
AT (1) AT355743B (US06650917-20031118-M00005.png)
BE (1) BE856862A (US06650917-20031118-M00005.png)
CH (1) CH627191A5 (US06650917-20031118-M00005.png)
DE (1) DE2632678C2 (US06650917-20031118-M00005.png)
DK (1) DK323877A (US06650917-20031118-M00005.png)
FR (1) FR2358421A1 (US06650917-20031118-M00005.png)
GB (1) GB1589585A (US06650917-20031118-M00005.png)
IT (1) IT1125789B (US06650917-20031118-M00005.png)
LU (1) LU77768A1 (US06650917-20031118-M00005.png)
NL (1) NL7707920A (US06650917-20031118-M00005.png)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2244000A (en) * 1990-05-18 1991-11-20 Teasdale S Mattress
US9744168B2 (en) 2011-10-19 2017-08-29 Galderma Laboratories, Inc. Method of reducing facial flushing associated with systemic use of phosphodiesterase type 5 inhibitors
US9861631B2 (en) 2010-03-26 2018-01-09 Galderma Laboratories, L.P. Methods and compositions for safe and effective treatment of erythema

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3053837A (en) * 1958-10-01 1962-09-11 Olin Mathieson 16, 17-acetal and ketal derivatives of 6alpha, 12alpha-dihalo-16alpha, 17alpha-dihydroxy steroids of the pregnane series; and intermediates therefor
GB1179547A (en) * 1965-12-22 1970-01-28 Squibb & Sons Inc 01beta,12beta-Oxido-16alpha-Methyl-Pregnenes

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2244000A (en) * 1990-05-18 1991-11-20 Teasdale S Mattress
US9861631B2 (en) 2010-03-26 2018-01-09 Galderma Laboratories, L.P. Methods and compositions for safe and effective treatment of erythema
US9861632B2 (en) 2010-03-26 2018-01-09 Galderma Laboratories, L.P. Methods and compositions for safe and effective treatment of erythema
US9744168B2 (en) 2011-10-19 2017-08-29 Galderma Laboratories, Inc. Method of reducing facial flushing associated with systemic use of phosphodiesterase type 5 inhibitors

Also Published As

Publication number Publication date
CH627191A5 (en) 1981-12-31
DE2632678A1 (de) 1978-01-26
ATA504777A (de) 1979-08-15
LU77768A1 (US06650917-20031118-M00005.png) 1977-10-17
NL7707920A (nl) 1978-01-18
IT1125789B (it) 1986-05-14
AT355743B (de) 1980-03-25
JPS5315361A (en) 1978-02-13
FR2358421A1 (fr) 1978-02-10
BE856862A (fr) 1978-01-16
DE2632678C2 (de) 1986-02-27
DK323877A (da) 1978-01-17
FR2358421B1 (US06650917-20031118-M00005.png) 1979-05-11

Similar Documents

Publication Publication Date Title
US4267173A (en) Use of 6β-fluoro-7α-halogenocorticoids as topical anti-inflammatories and pharmaceutical formulations useful therefor
US4472393A (en) 3,20-Dioxo-1,4-pregnadiene-17α-ol 17-aromatic heterocycle carboxylates
US4285937A (en) Novel androstadiene-17-carboxylic acid esters
US4607028A (en) Novel carboxylic acid esters
US4172132A (en) 1,3,5(10),6,8,14-19-Nor-pregnahexaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor
US4619921A (en) Polyhalogeno-steroids
US4226862A (en) Steroids and process for preparing the same
US4576936A (en) 6α-Fluoro-9α-chloro-prednisolone 17,21-diesters
US3984544A (en) Retinoic acid esters of steroids of the pregnane series, their use in the treatment of acne and pharmaceutical formulations useful therefor
JPS6411037B2 (US06650917-20031118-M00005.png)
US5082835A (en) Novel steroid diols, pharmaceutical compositions containing them and process for preparing same
US4243664A (en) Novel corticoids
GB1589585A (en) 12a-halocorticoids
JPS5837320B2 (ja) プレグナンサンユウドウタイ ノ セイホウ
IE45305B1 (en) New corticoids
US4107161A (en) Bis(triamcinolone acetonide)-4,4'-methylenebis-(3-methoxy-2-naphthoate)
GB1563638A (en) 21-halogenopregnane compounds
US4207316A (en) Novel 17-substituted 11 β-hydroxy steroids of the pregnane series, their manufacture, preparation and use
US4185101A (en) 1,3,5(10),6,8-19-Nor-pregnapentaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor
GB1594852A (en) Derivatives of 9-chloroprednisolone
US4008313A (en) Novel corticoids
US4221786A (en) Novel halogenopregnadienes and process for the manufacture thereof
US4261986A (en) 4-Halo etianic acids and derivatives thereof
GB1603281A (en) Derivatives of 9-fluoroprednisolone
EP0000609B1 (en) Novel 19-nor-pregnahexaenes, process for the preparation thereof, and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee